Cargando…
Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of mortality in India. Residual risk exists in patients receiving optimal guideline-directed medical therapy. Possession of certain somatic mutations, at a variant allele frequency of ≥ 2% in peripheral blood, driving clonal expansion...
Autores principales: | Senguttuvan, Nagendra Boopathy, Subramanian, Vinodhini, Venkatesan, Vettriselvi, Muralidharan, T. R., Sankaranarayanan, Kavitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287286/ https://www.ncbi.nlm.nih.gov/pubmed/34279740 http://dx.doi.org/10.1186/s43141-021-00205-3 |
Ejemplares similares
-
Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
por: Huang, Yi-Chun, et al.
Publicado: (2021) -
Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022) -
Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
por: Komic, Luka, et al.
Publicado: (2023) -
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
por: Gagnon, Marie-France, et al.
Publicado: (2022) -
Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
por: von Scheidt, Moritz, et al.
Publicado: (2023)